XYNOMIC PHARMACEUTICALS HOLDINGS, INC.: 10-Q filed 2019-08-15
What XYNOMIC PHARMACEUTICALS HOLDINGS, INC. reported in its quarterly report filed 2019-08-15 (fiscal Q2 2019): 30 published measures, 81 facts as tagged in accession 0001213900-19-016052.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-08-15
- Fiscal period
- fiscal Q2 2019
- Accession
- 0001213900-19-016052 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All XYNOMIC PHARMACEUTICALS HOLDINGS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 2,013,560 | USD | |
| At 2018-12-31 | 5,461,963 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 17,048,886 | USD | |
| At 2018-12-31 | 17,645,943 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | -15,035,326 | USD | |
| At 2019-03-31 | -28,290,970 | USD | |
| At 2018-12-31 | -20,094,728 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 1,191,944 | USD | |
| At 2018-12-31 | 4,746,370 | USD | |
| At 2018-06-30 | 788,957 | USD | |
| At 2017-12-31 | 100,344 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | -3,051,753 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -17,196,308 | USD | 181 |
| 2019-01-01 to 2019-03-31 | -14,144,555 | USD | 90 |
| 2018-04-01 to 2018-06-30 | -4,708,461 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -5,327,391 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | -7,982,084 | USD | 181 |
| 2018-01-01 to 2018-06-30 | -3,007,228 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | 52,340 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | -58,860,826 | USD | 181 |
| 2018-01-01 to 2018-06-30 | 5,336,546 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | 63,258,544 | USD | 181 |
| 2018-01-01 to 2018-06-30 | -1,640,705 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | -51,519,477 | USD | |
| At 2018-12-31 | -34,323,169 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 444,796 | USD | |
| At 2018-12-31 | 280,730 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | -30,317 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 7,652,965 | USD | 181 |
| 2019-01-01 to 2019-03-31 | 7,683,282 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | -3,034,030 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -17,163,497 | USD | 181 |
| 2018-04-01 to 2018-06-30 | -4,716,728 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -5,335,658 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 1,347,749 | USD | |
| At 2018-12-31 | 5,024,120 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 17,048,886 | USD | |
| At 2018-12-31 | 17,645,943 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | 3,034,030 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 17,163,497 | USD | 181 |
| 2018-04-01 to 2018-06-30 | 4,716,728 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 5,335,658 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | 1,567,799 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 6,892,109 | USD | 181 |
| 2018-04-01 to 2018-06-30 | 3,873,804 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 4,340,206 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 46,273,846 | shares | |
| At 2018-12-31 | 6,706,068 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 36,401,911 | USD | |
| At 2018-12-31 | 14,169,060 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 77,613 | USD | |
| At 2018-12-31 | 58,564 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 499,209 | USD | |
| At 2018-12-31 | 281,218 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 54,413 | USD | |
| At 2018-12-31 | 488 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 219,565 | USD | |
| At 2018-12-31 | 155,176 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-06-30 | 155,805 | USD | |
| At 2018-12-31 | 277,750 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | -4,708,461 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -5,327,391 | USD | 181 |
| 2018-04-01 to 2018-06-30 | -3,051,753 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -17,196,308 | USD | 181 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-06-30 | -17,196,308 | USD | 181 |
| 2018-01-01 to 2018-06-30 | -5,327,391 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | -2,995,713 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -18,875,237 | USD | 181 |
| 2018-04-01 to 2018-06-30 | -4,808,753 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -5,524,999 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | -3,051,753 | USD | 91 |
| 2019-01-01 to 2019-06-30 | -18,894,286 | USD | 181 |
| 2018-04-01 to 2018-06-30 | -4,808,753 | USD | 91 |
| 2018-01-01 to 2018-06-30 | -5,524,999 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | 1,443,731 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 10,222,980 | USD | 181 |
| 2018-04-01 to 2018-06-30 | 745,286 | USD | 91 |
| 2018-01-01 to 2018-06-30 | 848,761 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-04-01 to 2019-06-30 | 30,612 | USD | 91 |
| 2019-01-01 to 2019-06-30 | 54,593 | USD | 181 |
| 2018-04-01 to 2018-06-30 | 30,612 | USD | 91 |
Inspect the source
- Entity
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. / CIK 0001697805
- Captured
- SEC response SHA-256
997bbaa9f251c90a07a27c90047cc9b9cf444bf9ee3e54ae84b128a683a1ebe4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001697805.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))